Ann: Antisense Therapeutics Corporate Presentation, page-64

you'd have to get over 50c from a cash position of $150m, about to sell a drug, possible take over at any time. I'm not sure a dollar is out of the question at all by November next year. So when we get good results back from our 2b trial second half next year we not only jump up prior to results in anticipation, but then the result itself and then again on accelerated approval submission and then the under two months lead up to the fda's answer. Question is how long will we sit here under 15c before the market factors in these things. Last patient dosed will of course be a biggie, new calendar year turning over will set the countdown too I imagine.